Compare Enveric Biosciences Inc (ENVB) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while State Street SPDR S&P Homebuilders ETF trades at $110.5. The key difference: State Street SPDR S&P Homebuilders ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | XHB | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $17.40 | $121.36 |
52-Week Low | $1.27 | $94.86 |
Enterprise Value | $1.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
